The Skin Cancer Foundation Journal

MAY 2013

The 2012 edition of The Skin Cancer Foundation Journal features medically reviewed, reader-friendly articles such as tanning, the increasing incidence of skin cancer diagnoses among young women, & the prevalence of melanoma among white males over 50.

Issue link: https://skincancer.epubxp.com/i/131479

Contents of this Issue

Navigation

Page 74 of 103

Get screened for vitamin D defciency, and seek out dietary sources and supplements for daily use. Transplant patients should examine their skin head to toe each month and see a dermatologist for a full-body skin exam at least every year. is another option: lowering the immunosuppressant dose. Despite fears that this might wreak havoc with transplant patients' immune systems, evidence suggests that it can improve the skin cancer prognosis without jeopardizing the transplant.45 Skin cancers are a serious risk for transplant patients, but with rigorous sun safety practices and the ongoing research of dedicated scientists, patients and doctors are increasingly well equipped to prevent, detect, and treat their skin cancers. SuSan o'GoRMan, MD, is a Registrar in Dermatology to Dr. Gillian Murphy at Beaumont Hospital in Dublin, Ireland. Gillian M. MuRphy, MD, is Consultant Dermatologist and head of the National Photodermatology Unit at Beaumont and Mater Hospitals in Dublin, Ireland. Dr. Murphy has long had a major interest in skin cancer and the effects of ultraviolet radiation on human skin. She has published extensively on the problem of skin cancers in transplant patients. Beaumont Hospital is the national renal transplant center and the Mater is the national cardiac and lung transplant center. She has had a research program in these areas for many years. References available on p.95. TABLE 2: Strategies to Minimize Skin Cancer in Transplant Patients Photoprotection: sun and tanning avoidance, shade, protective clothing, high-sPF UvA/UvB sunscreen early detection of lesions; self-examination and frequent physician visits treatment of premaligant lesions, such as actinic keratoses reduction of immunosuppressant dose Use of immunosuppressants such as rapamycin Use of chemopreventative agents such as retinoids 73

Articles in this issue

Archives of this issue

view archives of The Skin Cancer Foundation Journal - MAY 2013